168
Participants
Start Date
March 30, 2019
Primary Completion Date
October 22, 2022
Study Completion Date
October 22, 2022
Mount Sinai, New York
Penn State Hershey Medical Center, Hershey
Institute for Asthma & Allergy - Chevy Chase, Chevy Chase
Duke Asthma, Allergy & Airway Center, Durham
Clinical Research of Charlotte, Charlotte
University of South Florida Asthma, Allergy & Immunology, Tampa
Clinical Research Center of Alabama, Birmingham
Bernstein Clinical Research Center, LLC, Cincinnati
University of Michigan, Ann Arbor
Mid West Immunology Clinic, Plymouth
Washington University, St Louis
University of Kansas Medical Center Research Institute, Inc., Kansas City
AARA Research Center, Dallas
Asthma and Allergy Associates, PC, Colorado Springs
Medical Research of Arizona, Scottsdale
AIRE Medical of Los Angeles, Santa Monica
University of California San Diego, San Diego
Portland Clinical Research/AAIM Care, Happy Valley
Seattle Allergy & Asthma Research Institute, Seattle
Yale University School of Medicine, New Haven
Massachusetts General Hospital, Boston
Riverside Medical Group, Belleville, Belleville
Jay M Kashkin, MD Allergy, Asthma and Immunology, Fair Lawn
University of Calgary - Heritage Medical Research Clinic, Calgary
McMaster University Health Sciences Center, Hamilton
St. Michael's Hospital, Toronto
CHUM Hôtel-Dieu, Montreal
Clinique Specialisée en Allergie de la Capitale, Québec
Rafael H Zaragoza-Urdaz, San Juan
Lead Sponsor
Takeda Development Center Americas, Inc.
INDUSTRY
Shire
INDUSTRY